Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Inflammation × Specimen Handling × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Breast 1

Conditions

Prostatic Neoplasms 38 Lung Neoplasms 32 Leukemia, Myeloid, Acute 32 Neoplasm Metastasis 28 Carcinoma, Non-Small-Cell Lung 28 Breast Neoplasms 27 Colorectal Neoplasms 18 Pancreatic Neoplasms 16 Myelodysplastic Syndromes 16 Leukemia, Lymphocytic, Chronic, B-Cell 16 Multiple Myeloma 15 Ovarian Neoplasms 14 Lymphoma, Large B-Cell, Diffuse 14 Endometrial Neoplasms 12 Carcinoma, Renal Cell 12 Urinary Bladder Neoplasms 11 Triple Negative Breast Neoplasms 11 Squamous Cell Carcinoma of Head and Neck 10 Melanoma 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Leukemia, Myelomonocytic, Chronic 9 Fallopian Tube Neoplasms 9 Burkitt Lymphoma 9 Oropharyngeal Neoplasms 8 Mouth Neoplasms 8 Lymphoma, B-Cell 8 Glioblastoma 8 Brain Neoplasms 8 Myeloproliferative Disorders 7 Lymphoma, Mantle-Cell 7

Interventions

palbociclib 1 microcrystalline cellulose 1 epigallocatechin gallate 1 dapagliflozin 1 Tablets 1 Specimen Handling 1 Selenium 1 Saline Solution 1 Pregabalin 1 Platelet Count 1 Plastic Surgery Procedures 1 Omeprazole 1 Losartan 1 Ketorolac 1 Infliximab 1 Immunotherapy, Adoptive 1 Dexmedetomidine 1 Cognitive Behavioral Therapy 1 Bevacizumab 1 Ascorbic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06150898 2025-06-13

KePreSt

Jules Bordet Institute

Phase 2 Recruiting

Breast Neoplasms, Inflammation, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡